130 related articles for article (PubMed ID: 6811149)
1. Tumor initiation by 7,12-dimethylbenz[a]anthracene in dermal melanocytes of hamster: inhibition through 7,8-benzoflavone.
Goerttler K; Loehrke H; Hesse B; Pyerin WG
Carcinogenesis; 1982; 3(7):791-5. PubMed ID: 6811149
[TBL] [Abstract][Full Text] [Related]
2. Two-stage tumorigenesis of dermal melanocytes in the back skin of the Syrian golden hamster using systemic initiation with 7,12-dimethylbenz(a)anthracene and topical promotion with 12-O-tetradecanoylphorbol-13-acetate.
Goerttler K; Loehrke H; Schweizer J; Hesse B
Cancer Res; 1980 Jan; 40(1):155-61. PubMed ID: 6765915
[No Abstract] [Full Text] [Related]
3. Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyldibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice.
Alworth WL; Slaga TJ
Carcinogenesis; 1985 Apr; 6(4):487-93. PubMed ID: 3921269
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the prenatal dimethylbenz[a]anthracene-induced tumour initiation in mice by prior administration of 7,8-benzoflavone.
Goerttler K; Loehrke H
Carcinogenesis; 1986 Jul; 7(7):1187-9. PubMed ID: 3087648
[TBL] [Abstract][Full Text] [Related]
5. [Effect of 7,8-benzoflavone on the incidence of skin tumors induced by polycyclic hydrocarbons].
Linnik AB; Kobliakov VA
Biull Eksp Biol Med; 1979 May; 87(5):454-5. PubMed ID: 110379
[TBL] [Abstract][Full Text] [Related]
6. Tumour initiation in mouse skin by 7,12-dimethylbenz[a]anthracene: irrelevance of systemic activation.
Pyerin WG; Hecker E
Cancer Lett; 1980 Feb; 8(4):317-21. PubMed ID: 6768444
[TBL] [Abstract][Full Text] [Related]
7. Skin tumor formation in the European hamster (Cricetus cricetus L.) after topical initiation with 7,12-dimethylbenz[a]anthracene (DMBA) and promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA).
Goerttler K; Loehrke H; Hesse B; Schweizer J
Carcinogenesis; 1984 Apr; 5(4):521-4. PubMed ID: 6423310
[TBL] [Abstract][Full Text] [Related]
8. The effects of benzoflavones on polycyclic hydrocarbon metabolism and skin tumor initiation.
Slaga TJ; Thompson S; Berry DL; Digiovanni J; Juchau MR; Viaje A
Chem Biol Interact; 1977 Jun; 17(3):297-312. PubMed ID: 407010
[TBL] [Abstract][Full Text] [Related]
9. Effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and its nonpromoting analogue 4-O-methyl-TPA on dorsal dermal melanocytes of the Syrian golden hamster (Mesocricetus auratus).
Goerttler K; Hecker E; Loehrke H; Seip H; Hesse B; Schweitzer J
J Cancer Res Clin Oncol; 1982; 103(3):305-11. PubMed ID: 6811595
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of alpha- and beta-naphthoflavones on DMBA-induced anomalies in germ cells assessed by sperm abnormality assay.
Raj AS; Katz M
Mutat Res; 1984 Apr; 136(1):81-4. PubMed ID: 6425684
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DMBA carcinogenesis of hamster buccal pouch by phenanthrene and dimethylnaphthalene.
Malament DS; Shklar G
Carcinogenesis; 1981; 2(8):723-9. PubMed ID: 6793258
[TBL] [Abstract][Full Text] [Related]
12. Formation of 7,12-dimethylbenz[alpha] anthracene-DNA adducts in 7,8-benzoflavone-treated hamster embryo cells.
Baird WM; Diamond L
Chem Biol Interact; 1978 Feb; 20(2):181-90. PubMed ID: 417810
[TBL] [Abstract][Full Text] [Related]
13. 9-Hydroxyellipticine: inhibitory effect on skin carcinogenesis induced in Swiss mice by 7,12-dimethylbenz[a]anthracene.
Lesca P; Mansuy D
Chem Biol Interact; 1980 May; 30(2):181-7. PubMed ID: 6771025
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of 7,8-benzoflavone on DMBA- and BaP-induced bone marrow micronuclei in mouse.
Raj AS; Katz M
Mutat Res; 1983 Aug; 110(2):337-42. PubMed ID: 6308436
[TBL] [Abstract][Full Text] [Related]
16. The reduction of tumor initiating activity and cell mediated mutagenicity of dimethylbenz[a]anthracene by a copper coordination compound.
Solanki V; Yotti L; Logani MK; Slaga TJ
Carcinogenesis; 1984 Jan; 5(1):129-31. PubMed ID: 6418405
[TBL] [Abstract][Full Text] [Related]
17. Dibenz[a,c]anthracene: a potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene.
Slaga TJ; Viaje A; Buty SG; Bracken WM
Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):477-83. PubMed ID: 418469
[TBL] [Abstract][Full Text] [Related]
18. The differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the initiation-promotion protocol and by the complete carcinogenesis process.
Verma AK
Carcinog Compr Surv; 1982; 7():35-9. PubMed ID: 6802491
[TBL] [Abstract][Full Text] [Related]
19. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice.
DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ
Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen.
Verma AK; Conrad EA; Boutwell RK
Cancer Res; 1982 Sep; 42(9):3519-25. PubMed ID: 6286109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
